Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Affimed (GB:0HL9)
LSE:0HL9
Affimed (0HL9) Stock Price & Analysis
0 Followers
0HL9 Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.65 - $3.31
Previous Close$0.89
Volume1.55K
Average Volume (3M)3.47K
Market Cap
$123.61M
Enterprise Value-$48.49M
Total Cash (Recent Filing)$190.29M
Total Debt (Recent Filing)$18.19M
Price to Earnings (P/E)N/A
Beta2.02
Next Earnings
Aug 09, 2023EPS Estimate
-$0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding149,339,335
10 Day Avg. Volume907
30 Day Avg. Volume3,467
Standard Deviation0.37
R-Squared0.05
Alpha0.08
Financial Highlights & Ratios
Price to Book (P/B)0.95
Price to Sales (P/S)20.16
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.61
Enterprise Value/Gross Profit-1.17
Enterprise Value/Ebitda0.96
Forecast
1Y Price Target
$4.50Price Target Upside405.05% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Affimed News
0HL9 FAQ
What was Affimed’s price range in the past 12 months?
Affimed lowest stock price was $0.65 and its highest was $3.31 in the past 12 months.
What is Affimed’s market cap?
Currently, no data Available
When is Affimed’s upcoming earnings report date?
Affimed’s upcoming earnings report date is Aug 09, 2023 which is in 73 days.
How were Affimed’s earnings last quarter?
Affimed released its earnings results on May 23, 2023. The company reported -$0.225 earnings per share for the quarter, missing the consensus estimate of -$0.206 by -$0.019.
Is Affimed overvalued?
According to Wall Street analysts Affimed’s price is currently Undervalued.
Does Affimed pay dividends?
Affimed does not currently pay dividends.
What is Affimed’s EPS estimate?
Affimed’s EPS estimate is -$0.2.
How many shares outstanding does Affimed have?
Currently, no data Available
What happened to Affimed’s price movement after its last earnings report?
Affimed reported an EPS of -$0.225 in its last earnings report, missing expectations of -$0.206. Following the earnings report the stock price went down -4.766%.
Which hedge fund is a major shareholder of Affimed?
Among the largest hedge funds holding Affimed’s share is Baker Bros Advisors LP. It holds Affimed’s shares valued at 5M.
---
Affimed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.50 (405.05% Upside)
$4.50 (405.05% Upside)
Blogger Sentiment
Neutral
GB:0HL9 Sentiment 50%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-73.74%
12-Months-Change
Fundamentals
Return on Equity
-79.30%
Trailing 12-Months
Asset Growth
-15.13%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Affimed
Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany.
---
---